RespireRx Pharmaceuticals Inc. (RSPI)
OTCMKTS · Delayed Price · Currency is USD
0.0014
+0.0001 (7.69%)
At close: Oct 8, 2025
RespireRx Pharmaceuticals Market Cap
RespireRx Pharmaceuticals has a market cap or net worth of $1.23 million as of October 8, 2025. Its market cap has increased by 99.16% in one year.
Market Cap
1.23M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 1, 1992, RespireRx Pharmaceuticals's market cap has decreased from 26.39M to 1.23M, a decrease of -95.32%. That is a compound annual growth rate of -8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 1.33M | 75.00% |
| Dec 31, 2024 | 759.57K | 65.58% |
| Dec 29, 2023 | 458.74K | 58.87% |
| Dec 30, 2022 | 288.75K | -74.38% |
| Dec 31, 2021 | 1.13M | -45.46% |
| Dec 31, 2020 | 2.07M | 411.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |